This record was last updated December 26, 2025 (before its estimated March 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
The intervention in this study consists of a 75-min intraduodenal infusion of an isotonic solution containing either of calcium chloride (CaCl2) or control (saline).
Participants enrolled into the study will receive, in randomised, double-blind fashion (i) Saline (control), (ii) 500 mg CaCl2, or (iii) 1000 mg CaCl2 in three separate sessions, each of which will be separated by at least 4 (and up to 10) days. Each study session will be 4-6 hours. Studies will be carried out in the Clinical Research Facility of the Adelaide Medical School, the University of Adelaide, by staff and students trained in the required techniques.
Protocol Amendment History
1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-16.
Status change: Not Yet Recruiting → Recruiting2025-12-18